92 related articles for article (PubMed ID: 3021153)
1. 1,25-Dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells.
Yamaoka K; Marion SL; Gallegos A; Haussler MR
Biochem Biophys Res Commun; 1986 Sep; 139(3):1292-8. PubMed ID: 3021153
[TBL] [Abstract][Full Text] [Related]
2. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
3. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
4. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.
Colston K; Colston MJ; Feldman D
Endocrinology; 1981 Mar; 108(3):1083-6. PubMed ID: 6257495
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids increase the 1,25(OH)2D3 receptor concentration in rat osteogenic sarcoma cells.
Manolagas SC; Abare J; Deftos LJ
Calcif Tissue Int; 1984 Mar; 36(2):153-7. PubMed ID: 6331611
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.
Pols HA; Birkenhäger JC; Schilte JP; Visser TJ
Biochim Biophys Acta; 1988 Jun; 970(2):122-9. PubMed ID: 2838094
[TBL] [Abstract][Full Text] [Related]
8. Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cells.
Pols HA; Schilte HP; Visser TJ; Birkenhager JC
Biochim Biophys Acta; 1987 Nov; 931(2):115-9. PubMed ID: 2822140
[TBL] [Abstract][Full Text] [Related]
9. The effects of sodium butyrate on the retinoic acid-induced changes in 1,25-dihydroxyvitamin D3 receptors in tumorigenic and nontumorigenic bone derived cell lines.
Lee KL; Petkovich PM; Heersche JN
Endocrinology; 1988 Jun; 122(6):2399-406. PubMed ID: 2836162
[TBL] [Abstract][Full Text] [Related]
10. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
[TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells.
Pan LC; Price PA
J Biol Chem; 1987 Apr; 262(10):4670-5. PubMed ID: 3031030
[TBL] [Abstract][Full Text] [Related]
12. Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
Biochem Biophys Res Commun; 1990 Jun; 169(2):629-35. PubMed ID: 2162670
[TBL] [Abstract][Full Text] [Related]
13. Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3.
Manolagas SC; Provvedini DM; Murray EJ; Murray SS; Tsonis PA; Spandidos DA
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):856-60. PubMed ID: 3027709
[TBL] [Abstract][Full Text] [Related]
14. Relative resistance to 1,25-dihydroxyvitamin D3 in a keratinocyte model of tumor progression.
Sebag M; Henderson J; Rhim J; Kremer R
J Biol Chem; 1992 Jun; 267(17):12162-7. PubMed ID: 1318311
[TBL] [Abstract][Full Text] [Related]
15. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
16. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
Hosoi J; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
[TBL] [Abstract][Full Text] [Related]
17. Activation of the 1,25-dihydroxyvitamin D3 receptor in cultured rat osteogenic sarcoma cells.
Werntz DA; Catherwood BD; Deftos LJ; Manolagas SC
J Recept Res; 1985; 5(2-3):147-54. PubMed ID: 2993603
[TBL] [Abstract][Full Text] [Related]
18. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
19. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
Eisman JA; Barkla DH; Tutton PJ
Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone.
Gross M; Kost SB; Ennis B; Stumpf W; Kumar R
J Bone Miner Res; 1986 Oct; 1(5):457-67. PubMed ID: 2845731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
